Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nutt

Showing results (371-380 of 790) with videos related to

Pageof 79
Sort By:
Behavioural Brain Research|June 27, 2012
Evaluation of an operant successive negative contrast task as a method to study affective state in rodentsEmma N Mitchell, Hugh M Marston, David J Nutt, et al.
Experimental and Clinical Psychopharmacology|December 29, 2000
The processing of automatic thoughts of drug use and craving in opiate-dependent individualsA M Weinstein, B T Feldtkeller, F Law, et al.
Molecular Ecology Resources|May 19, 2011
PERMANENT GENETIC RESOURCES: Isolation and characterization of microsatellite loci in the North Island brown kiwi, Apteryx mantelliThomas Jensen, Karen J Nutt, Bruce S Seal, et al.
Journal of Neuroscience Methods|August 2, 2005
The uptake of a fluorescently labelled antisense oligonucleotide in vitro and in vivoEmma S J Robinson, David J Nutt, Helen C Jackson, et al.
Addiction Biology|February 23, 2017
Addiction research and theory: a commentary on the Surgeon General's Report on alcohol, drugs, and healthAldo Badiani, Kent C Berridge, Markus Heilig, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 4, 2012
The effect of 6-week treatment with escitalopram on CCK-4 challenge: a placebo-controlled study in CCK-4-sensitive healthy volunteersInnar Tõru, Eduard Maron, Mait Raag, et al.
Journal of Psychopharmacology (Oxford, England)|October 28, 2025
A long, strange trip: Ketamine treatment in psychiatryDavid J Nutt, Celia Morgan, David Erritzoe, et al.
Frontiers in Human Neuroscience|June 7, 2014
The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteersLeor Roseman, Robert Leech, Amanda Feilding, et al.
Journal of Psychopharmacology (Oxford, England)|May 1, 2023
A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depressionBrandon Weiss, David Erritzoe, Bruna Giribaldi, et al.
European Journal of Pharmacology|August 15, 2002
Distribution of [(3)H]BU224, a selective imidazoline I(2) binding site ligand, in rat brainEmma S J Robinson, Robin J Tyacke, David J Nutt, et al.
Pageof 79

Showing results (371-380 of 790) with videos related to

Sort By:
Pageof 79
Behavioural Brain Research|June 27, 2012
Evaluation of an operant successive negative contrast task as a method to study affective state in rodentsEmma N Mitchell, Hugh M Marston, David J Nutt, et al.
Experimental and Clinical Psychopharmacology|December 29, 2000
The processing of automatic thoughts of drug use and craving in opiate-dependent individualsA M Weinstein, B T Feldtkeller, F Law, et al.
Molecular Ecology Resources|May 19, 2011
PERMANENT GENETIC RESOURCES: Isolation and characterization of microsatellite loci in the North Island brown kiwi, Apteryx mantelliThomas Jensen, Karen J Nutt, Bruce S Seal, et al.
Journal of Neuroscience Methods|August 2, 2005
The uptake of a fluorescently labelled antisense oligonucleotide in vitro and in vivoEmma S J Robinson, David J Nutt, Helen C Jackson, et al.
Addiction Biology|February 23, 2017
Addiction research and theory: a commentary on the Surgeon General's Report on alcohol, drugs, and healthAldo Badiani, Kent C Berridge, Markus Heilig, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 4, 2012
The effect of 6-week treatment with escitalopram on CCK-4 challenge: a placebo-controlled study in CCK-4-sensitive healthy volunteersInnar Tõru, Eduard Maron, Mait Raag, et al.
Journal of Psychopharmacology (Oxford, England)|October 28, 2025
A long, strange trip: Ketamine treatment in psychiatryDavid J Nutt, Celia Morgan, David Erritzoe, et al.
Frontiers in Human Neuroscience|June 7, 2014
The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteersLeor Roseman, Robert Leech, Amanda Feilding, et al.
Journal of Psychopharmacology (Oxford, England)|May 1, 2023
A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depressionBrandon Weiss, David Erritzoe, Bruna Giribaldi, et al.
European Journal of Pharmacology|August 15, 2002
Distribution of [(3)H]BU224, a selective imidazoline I(2) binding site ligand, in rat brainEmma S J Robinson, Robin J Tyacke, David J Nutt, et al.
Pageof 79